These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 1324645

  • 21. Azithromycin for acute lower respiratory tract infections.
    Panpanich R, Lerttrakarnnon P, Laopaiboon M.
    Cochrane Database Syst Rev; 2004 Oct 18; (4):CD001954. PubMed ID: 15497172
    [Abstract] [Full Text] [Related]

  • 22. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zeckel ML, Jacobson KD, Guerra FJ, Therasse DG, Farlow D.
    Clin Ther; 1992 Oct 18; 14(2):214-29. PubMed ID: 1611645
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
    Sethi S, Breton J, Wynne B.
    Antimicrob Agents Chemother; 2005 Jan 18; 49(1):153-60. PubMed ID: 15616290
    [Abstract] [Full Text] [Related]

  • 24. Azithromycin for acute lower respiratory tract infections.
    Panpanich R, Lerttrakarnnon P, Laopaiboon M.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD001954. PubMed ID: 18253999
    [Abstract] [Full Text] [Related]

  • 25. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
    Wasilewski MM, Johns D, Sides GD.
    J Antimicrob Chemother; 1999 Apr 23; 43(4):541-8. PubMed ID: 10350384
    [Abstract] [Full Text] [Related]

  • 26. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
    File T, Schlemmer B, Garau J, Lode H, Lynch S, Young C.
    J Chemother; 2000 Aug 23; 12(4):314-25. PubMed ID: 10949981
    [Abstract] [Full Text] [Related]

  • 27. High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.
    Arrieta A, Arguedas A, Fernandez P, Block SL, Emperanza P, Vargas SL, Erhardt WA, de Caprariis PJ, Rothermel CD.
    Antimicrob Agents Chemother; 2003 Oct 23; 47(10):3179-86. PubMed ID: 14506028
    [Abstract] [Full Text] [Related]

  • 28. Clinical efficacy of azithromycin in lower respiratory tract infections.
    Morandini G, Perduca M, Zannini G, Foschino MP, Miragliotta G, Carnimeo NS.
    J Chemother; 1993 Feb 23; 5(1):32-6. PubMed ID: 8384658
    [Abstract] [Full Text] [Related]

  • 29. Role of nasopharyngeal culture in antibiotic prescription for patients with common cold or acute sinusitis.
    Kaiser L, Morabia A, Stalder H, Ricchetti A, Auckenthaler R, Terrier F, Hirschel B, Khaw N, Lacroix JS, Lew D.
    Eur J Clin Microbiol Infect Dis; 2001 Jul 23; 20(7):445-51. PubMed ID: 11561799
    [Abstract] [Full Text] [Related]

  • 30. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
    Dark D.
    Am J Med; 1991 Sep 12; 91(3A):31S-35S. PubMed ID: 1656740
    [Abstract] [Full Text] [Related]

  • 31. A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children.
    Aronovitz G.
    Pediatr Infect Dis J; 1996 Sep 12; 15(9 Suppl):S15-9. PubMed ID: 8878241
    [Abstract] [Full Text] [Related]

  • 32. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.
    Dunn CJ, Barradell LB.
    Drugs; 1996 Mar 12; 51(3):483-505. PubMed ID: 8882383
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis.
    Beghi G, Berni F, Carratù L, Casalini A, Consigli G, D'Antò M, Gioia V, Molino A, Paizis G, Vaghi A.
    J Chemother; 1995 Apr 12; 7(2):146-52. PubMed ID: 7666122
    [Abstract] [Full Text] [Related]

  • 34. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Clin Ther; 1995 Apr 12; 17(5):861-74. PubMed ID: 8595638
    [Abstract] [Full Text] [Related]

  • 35. Azithromycin for acute lower respiratory tract infections.
    Laopaiboon M, Panpanich R, Swa Mya K.
    Cochrane Database Syst Rev; 2015 Mar 08; 2015(3):CD001954. PubMed ID: 25749735
    [Abstract] [Full Text] [Related]

  • 36. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE, Cranfield R, Breisch S, Pettit R.
    J Antimicrob Chemother; 1997 Dec 08; 40 Suppl A():63-72. PubMed ID: 9484875
    [Abstract] [Full Text] [Related]

  • 37. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R, Martínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA.
    Pediatr Pulmonol; 2003 Feb 08; 35(2):91-8. PubMed ID: 12526069
    [Abstract] [Full Text] [Related]

  • 38. Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
    Berry V, Thorburn CE, Knott SJ, Woodnutt G.
    Antimicrob Agents Chemother; 1998 Dec 08; 42(12):3193-9. PubMed ID: 9835514
    [Abstract] [Full Text] [Related]

  • 39. Loracarbef (LY163892) versus amoxicillin/clavulanate in the treatment of acute purulent bacterial bronchitis.
    Dere WH, Farlow D, Therasse DG, Jacobson KD, Guerra FJ.
    Clin Ther; 1992 Dec 08; 14(2):166-77. PubMed ID: 1611641
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerance of erythromycin acistrate in the treatment of acute exacerbations of chronic bronchitis in the elderly.
    Forsén KO, Wikberg R, Lehtonen L.
    Chemotherapy; 1993 Dec 08; 39(6):443-52. PubMed ID: 8222874
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.